PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
10-Jan-2022 Pfizer Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and Therapeutics Businesswire
10-Jan-2022 Pfizer and Beam Enter Exclusive Multi-Target Research Collaboration to Advance Novel In Vivo Base Editing Programs for a Range of Rare Diseases Businesswire
10-Jan-2022 Humanigen Aligns with FDA on Potential Registration Phase 3 Study for Lenzilumab with CAR-T Businesswire
10-Jan-2022 Global Dental Bone Grafts & Substitutes Market Research Report (2021 to 2026) - by Material Type, Application, End-user and Region - ResearchAndMarkets.com Businesswire
10-Jan-2022 TISSIUM Appoints Ruth Krestin as Vice President of Portfolio Strategy Businesswire
10-Jan-2022 Antibody Drug Conjugate Market Research Report 2022 by Mechanism of Action, Drugs, Technology, Application, End User - Global Forecast to 2027 - ResearchAndMarkets.com Businesswire
10-Jan-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
10-Jan-2022 Scailyte Closes Financing Round and Onboards Top Biotech Leaders to Prepare for Growth in 2022 Newswire
10-Jan-2022 Iksuda Therapeutics Deepens Clinical Pipeline Through Licensing Agreement for Her2 Antibody Drug Conjugate Programme From LegoChem Biosciences Businesswire
10-Jan-2022 NANOBIOTIX Provides Corporate Update and Highlights Key 2022 Milestone Targets Businesswire
10-Jan-2022 Celyad Oncology Provides Outlook for 2022 Businesswire
10-Jan-2022 Pharmaron Acquires Commercial API Manufacturing Facility in the United Kingdom from Recipharm Businesswire
09-Jan-2022 Exelixis Announces Preliminary Fourth Quarter and Full Year 2021 Financial Results, Provides 2022 Financial Guidance, and Outlines Key Priorities and Milestones for 2022 Businesswire
09-Jan-2022 Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coast 2022 SMi Group
08-Jan-2022 NVAX DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Novavax, Inc. of Deadline in Securities Fraud Class Action Lawsuit Businesswire
07-Jan-2022 INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Securities Class Action Lawsuit Has Been Filed on Behalf of Revance Therapeutics, Inc. (RVNC) Investors and Encourages Investors to Contact the Firm Before February 8, 2022 Businesswire
07-Jan-2022 Mary Kay Inc. & Mary Kay Ash FoundationSM Celebrate 2021 Year-End Highlights Businesswire
07-Jan-2022 Merck to Hold Fourth-Quarter and Full-Year 2021 Sales and Earnings Conference Call on February 3 Businesswire
07-Jan-2022 Apollo and Anjac Announce Closing of Arrangement Businesswire
07-Jan-2022 Worldwide Chronic Kidney Disease Industry to 2026 - North America is Expected to Hold the Largest Market Share - ResearchAndMarkets.com Businesswire